BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33125737)

  • 21. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
    Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
    Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underutilization of Surgery in Periampullary Cancer Treatment.
    Michalski CW; Liu B; Heckler M; Roth S; Sun H; Heger U; Büchler MW; Hackert T
    J Gastrointest Surg; 2019 May; 23(5):959-965. PubMed ID: 30088190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing survival after resection for periampullary neoplasms.
    Bouvet M; Gamagami RA; Gilpin EA; Romeo O; Sasson A; Easter DW; Moossa AR
    Am J Surg; 2000 Jul; 180(1):13-7. PubMed ID: 11036132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there an Optimal Surgical Approach to Neuroendocrine Tumors of the Ampulla? A Single Institution Experience Over 15 Years.
    Baptiste GG; Postlewait LM; Ethun CG; Le N; Russell MC; Kooby DA; Staley CA; Maithel SK; Cardona K
    Am Surg; 2016 Jul; 82(7):637-43. PubMed ID: 27457864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater.
    Yang K; Yun SP; Kim S; Shin N; Park DY; Seo HI
    BMC Gastroenterol; 2017 May; 17(1):70. PubMed ID: 28569146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of peri-ampullary tumors: a retrospective study.
    Fathy O; Abdel-Wahab M; Elghwalby N; Sultan A; El-Ebidy G; Abu-Zeid M; Abd-Allah T; El-Shobary M; Fouad A; Kandeel T; Abo-Elenien A; El-Hah NG; Abdel-Raouf A; Sultan AM; Ezzat F
    Hepatogastroenterology; 2008; 55(85):1463-9. PubMed ID: 18795713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periampullary tumors: which ones should be resected?
    Jones BA; Langer B; Taylor BR; Girotti M
    Am J Surg; 1985 Jan; 149(1):46-52. PubMed ID: 3966641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
    You D; Heo J; Choi S; Choi D; Jang KT
    Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
    Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
    Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormone inactive neuroendocrine tumors of the pancreas].
    Schwab M; Knoll MR; Jentschura D; Hagmüller E
    Chirurg; 1997 Jul; 68(7):705-9. PubMed ID: 9340236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
    Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
    World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging Computed Tomography in Patients With Noncurative Laparotomy for Periampullary Cancer: Does Nonstructured Reporting Adequately Communicate Resectability?
    Marshall HR; Hawel J; Meschino M; Wiseman D; Mujoomdar A; Lau E; Leslie K; Yoshy C
    Can Assoc Radiol J; 2018 Feb; 69(1):97-104. PubMed ID: 29224737
    [No Abstract]   [Full Text] [Related]  

  • 34. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
    Roder JD; Siewert JR
    Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical therapy of pancreatic and periampullary carcinoma in elderly patients].
    Benhidjeb T; Zanow J
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():489-91. PubMed ID: 9101908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis.
    Skipworth JR; Morkane C; Raptis DA; Vyas S; Olde Damink SW; Imber CJ; Pereira SP; Malago M; West N; Phillips RK; Clark SK; Shankar A
    HPB (Oxford); 2011 May; 13(5):342-9. PubMed ID: 21492334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic transduodenal local resection of periampullary neuroendocrine tumor: a case report.
    Zhang RC; Xu XW; Wu D; Zhou YC; Ajoodhea H; Chen K; Mou YP
    World J Gastroenterol; 2013 Oct; 19(39):6693-8. PubMed ID: 24151401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First results from the Swedish National Pancreatic and Periampullary Cancer Registry.
    Tingstedt B; Andersson B; Jönsson C; Formichov V; Bratlie SO; Öhman M; Karlsson BM; Ansorge C; Segersvärd R; Gasslander T
    HPB (Oxford); 2019 Jan; 21(1):34-42. PubMed ID: 30097413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.